• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Short-term growth in asthmatic children using fluticasone propionate.

作者信息

Visser M J, van Aalderen W M, Elliott B M, Odink R J, Brand P L

机构信息

Department of Pediatric Pulmonology, Beatrix Children's Hospital, University Hospital Groningen, The Netherlands.

出版信息

Chest. 1998 Mar;113(3):584-6. doi: 10.1378/chest.113.3.584.

DOI:10.1378/chest.113.3.584
PMID:9515828
Abstract

BACKGROUND

Inhaled corticosteroids may reduce short-term growth velocity in asthmatic children and knemometry is the most sensitive tool to detect this short-term growth suppression.

STUDY OBJECTIVE

To compare lower leg growth velocity, as measured by knemometry, in asthmatic children during and after treatment with inhaled fluticasone propionate (FP), 100 microg twice daily.

DESIGN

Nonrandomized open trial.

SETTING

University hospital, outpatient clinic for pediatric pulmonology.

PATIENTS

Twenty-one asthmatic children (13 boys), aged 6 to 10 years.

INTERVENTIONS

Inhalation of FP from a dry powder inhaler, 100 microg, twice daily for 6 weeks, followed by 2 weeks during which only an inhaled beta2-agonist was used on demand (washout). During treatment and washout periods, patients were seen every 2 weeks at the same time of day.

MEASUREMENTS AND RESULTS

Lower leg growth velocity measured by knemometry during FP treatment was not significantly different from that during washout (p=0.33, one-way analysis of variance).

CONCLUSIONS

No significant suppression of lower leg growth velocity was found in prepubertal asthmatic children using FP, 100 microg, by dry powder inhaler twice daily for 6 weeks.

摘要

相似文献

1
Short-term growth in asthmatic children using fluticasone propionate.
Chest. 1998 Mar;113(3):584-6. doi: 10.1378/chest.113.3.584.
2
Short-term knemometry and urine cortisol excretion in children treated with fluticasone propionate and budesonide: a dose response study.丙酸氟替卡松和布地奈德治疗儿童的短期小腿测量法及尿皮质醇排泄:一项剂量反应研究。
Eur Respir J. 1997 Jul;10(7):1507-12. doi: 10.1183/09031936.97.10071507.
3
Short-Term Growth During Treatment with Inhaled Fluticasone Propionate/Formoterol, Fluticasone and Beclomethasone Treatment.短期治疗期间吸入丙酸氟替卡松/福莫特罗、氟替卡松和倍氯米松的生长。
J Aerosol Med Pulm Drug Deliv. 2017 Oct;30(5):373-380. doi: 10.1089/jamp.2016.1335. Epub 2017 May 16.
4
Knemometry Assessment of Short-term Growth in Children With Asthma Receiving Fluticasone Furoate for 2 Weeks: A Randomized, Placebo-controlled, Crossover Trial.糠酸氟替卡松治疗2周的哮喘儿童短期生长的骨测量评估:一项随机、安慰剂对照、交叉试验
Clin Ther. 2017 Jun;39(6):1191-1199. doi: 10.1016/j.clinthera.2017.04.011. Epub 2017 May 22.
5
Short-term growth during treatment with inhaled fluticasone propionate and beclomethasone dipropionate.丙酸氟替卡松和二丙酸倍氯米松治疗期间的短期生长情况。
Arch Dis Child. 1993 May;68(5):673-6. doi: 10.1136/adc.68.5.673.
6
The effect of low-dose inhaled fluticasone propionate on exhaled nitric oxide in asthmatic patients and comparison with oral zafirlukast.低剂量吸入丙酸氟替卡松对哮喘患者呼出气一氧化氮的影响及其与口服扎鲁司特的比较。
Ann Allergy Asthma Immunol. 2001 Oct;87(4):283-8. doi: 10.1016/S1081-1206(10)62241-7.
7
Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.吸入用沙美特罗/丙酸氟替卡松联合制剂:其在持续性哮喘中应用的综述
Drugs. 2000 Nov;60(5):1207-33. doi: 10.2165/00003495-200060050-00012.
8
Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects.健康受试者和哮喘受试者使用干粉吸入器吸入丙酸氟替卡松和布地奈德的全身效应比较。
Thorax. 2001 Mar;56(3):186-91. doi: 10.1136/thorax.56.3.186.
9
Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma.通过吸入器每日一次或两次给予丙酸氟替卡松粉末对中度哮喘患者的长期疗效和安全性。
Chest. 2000 Aug;118(2):303-12. doi: 10.1378/chest.118.2.303.
10
Growth during one year of treatment with fluticasone propionate or sodium cromoglycate in children with asthma.
Pediatr Pulmonol. 1997 Sep;24(3):178-86. doi: 10.1002/(sici)1099-0496(199709)24:3<178::aid-ppul3>3.0.co;2-j.

引用本文的文献

1
The effect of asthma and its treatment on growth.哮喘及其治疗对生长发育的影响。
Arch Dis Child. 2004 Jan;89(1):60-3. doi: 10.1136/adc.2003.014365.
2
Safety of the newer inhaled corticosteroids in childhood asthma.新型吸入性糖皮质激素在儿童哮喘中的安全性。
Paediatr Drugs. 2003;5(7):481-504. doi: 10.2165/00128072-200305070-00005.
3
Effects of inhaled corticosteroids on growth in asthmatic children.吸入性糖皮质激素对哮喘儿童生长发育的影响。
Curr Allergy Asthma Rep. 2001 Mar;1(2):122-6. doi: 10.1007/s11882-001-0079-2.
4
Inhaled fluticasone propionate. A pharmacoeconomic review of its use in the management of asthma.吸入用丙酸氟替卡松。其在哮喘管理中应用的药物经济学综述。
Pharmacoeconomics. 2000 Nov;18(5):487-510. doi: 10.2165/00019053-200018050-00008.